In our recent study on the monohydroxy triterpenoid (triterpene monol) constituents of the nonsaponifiable lipid (NSL) fraction of camellia oil from Camellia japonica L. (Theaceae) and related sasanqua oil from C. sasanqua THUNB., we have isolated and characterized 27 tetracyclic and pentacyclic triterpenoids 1) and six incompletely cyclized triterpenoids. [2] [3] [4] [5] Upon evaluation of the antiinflammatory effects on 12-O-tetradecanoylphorbol-13-acetate (TPA)-induced inflammation in mice, 14 tetracyclic and pentacyclic triterpenoids were shown to have inhibitory effects. 1) In this paper, we report the isolation and characterization of a triterpenoid, 3-epicabraleahydroxylactone [1; (20S)-3b-hydroxy-25,26,27-trisnordammaran-24, 20 -olide], which is known as a semisynthetic compound 6) but is a new natural product, along with six known trieterpenoids, 3-epicabraleadiol (2), ocotillol II (3), ocotillol I (4), dammarenediol II (5), (20R)-taraxastane-3b,20-diol (6) , and lupane-3b,20-diol (7) , from the dihydroxy triterpenoid (triterpene diol) fraction of the NSL fraction obtained from camellia oil, as well as their inhibitory effects on Epstein-Barr virus early antigen (EBV-EA) activation induced by TPA, as a primary screening for antitumor promoters.
Seven triterpenoids, 1-7, among which compound 1 was a new naturally occurring compound, were isolated and characterized from the dihydroxy triterpenoid fraction obtained from the NSL fraction of camellia oil in this study. Compound 6 was previously isolated from Canarium strictum (Dipterocarpaceae) 7) and from Mangifera indica (Anacardiaceae), 8) but the stereochemistry at C-20 remained undetermined. Characterization of a new naturally occurring triterpenoid 1 and the determination of the stereochemistry at C-20 of 6, as described below, were performed on their 3-acetyl derivatives, 1a and 6a, respectively. The 13 C-and 1 H-NMR spectra (Table 1) of compound 1a (C 29 H 46 O 4 ) showed the presence of a g-lactone ring, 9) a tertiary methyl adjacent to the lactone ring, five other tertiary methyls, and a secondary acetoxyl group oriented equatorially (b) at C-3.
1) The 1 H-NMR signals for the ring system protons of 1a were very close to those for the corresponding 1 H signals of 3-epicabraleadiol 3-acetate (2a). 10) Furthermore, analysis of 13 C distortionless enhancement by polarization transfer (DEPT)-NMR, 1 H-1 H correlation spectroscopy (COSY), 1 H-detected multiple-quantum coherence (HMQC), and heteronuclear multiple-quantum coherence (HMBC) spectra of 1a enabled us to establish its structure as 3b-acetoxy-25,26,27-trisnordammaran-24,20-olide. The phase-sensitive nuclear Overhauser enhancement and exchange spectroscopy (NOESY) spectrum of compound 1a showed significant NOE correlations between (H-29-H-19-H-18-H-13b-H-21) on the b-face, and (H-28-H-3a-H-5a-H-9a-H-30-H-17a) on the a-face of the molecule, which supported the proposed structure. The structure of 1a was finally confirmed to be (20S)-3b-acetoxy-25,26,27-trisnordammaran-24,20-olide (3-epicabraleahydroxylactone 3-acetate) by direct comparison of the MS and 1 H-NMR data with semisynthetic 1a (20S) prepared from 2a (20S, 24S) by chromium trioxide oxidation of its 25-hydroxy-20,24-epoxydized C 8 -side chain into the trisnor-g-lactonized C 5 -side chain, 11) as described in Experimental.
Compound 6a (C 32 H 54 O 3 ) was identified as taraxastane3b,20x-diol 3-acetate 7, 8) by MS and 1 H-NMR (Table 1) This study demonstrated the presence of a triterpenoid 1 in the NSL fraction of camellia oil. Although compound 1 has previously been semisynthesized from its C-3a epimer, cabrareahydroxylactone [(20S)-3a-hydroxy-25,26,27-trisnordammaran-24,20-olide], 6) a component of Cabralea polytricha 6) and Cabralea eichleriana (Meliaceae), 12) to the best of our knowledge this is the first instance of its isolation from a natural source. Lactones are susceptible to hydrolytic ring opening in basic solution, and the isolation of compound 1 in this study may be attributed to its elution from the base-catalyzed saponification of the oil.
3-Epicabraleahydroxylactone and Other Triterpenoids from Camellia Oil and Their Inhibitory Effects on Epstein-Barr Virus Activation
The inhibitory effects of compounds 1-7 on EBV-EA activation induced by TPA were examined for the primary screening of antitumor-promoting activities, and the results are shown in ratio/32 pmol TPA), which has been intensively studied in cancer prevention using animal models.
13) It appears that epoxidation at C-20-C-24 of the side chain leads to a decrease in the activity as observed for the dammarane triterpenoids (1-5). The inhibitory effects against EBV-EA activation have been demonstrated to be closely parallel to those against tumor promotion in vivo, 14) and the triterpenoids 5-7 from camellia oil were therefore suggested to be valuable antitumor promoters (potential cancer chemopreventive agents).
Experimental
Crystallizations were performed from methanol (MeOH), and melting points are uncorrected. Optical rotations were measured on a JASCO DIP-370 polarimeter in CHCl 3 at 25°C. IR spectra were recorded on a JASCO IR-300 spectrometer in KBr disks. NMR spectra were recorded with a JEOL LA-500 spectrometer at 500 MHz ( 1 H-NMR) and 125 MHz ( (Tokyo, Japan), by the procedure described in the literature, 15) followed by preparative HPLC as the acetyl derivative 5a [retention time (t R ) 28.9 min]. Identification of 5a was performed by 13 C-NMR comparison with data in the literature. 16 ) TPA was purchased from ChemSyn Laboratories (Lenexa, KS, U.S.A.). The cell culture reagents, n-butyric acid, and other reagents were purchased from Nacalai Tesque, Inc. (Kyoto, Japan).
Extraction and Isolation Alkaline hydrolysis of the camellia oil (4.4 kg) followed by diisopropyl ether extraction yielded a neutral NSL fraction (14.2 g). The NSL was chromatographed on a silica gel (500 g) column with stepwise gradient of n-hexane-EtOAc (1 : 0, 95 : 5, 9 : 1, 4 : 1, 1 : 1, 0 : 1; v/v) as eluant. n-Hexane-EtOAc (9 : 1) eluted a fraction (7.6 g; fraction A) and n-hexane-EtOAc (1 : 1) eluted a fraction (1.8 g; fraction B ). Upon acetylation, fractions A and B gave the corresponding acetate fractions A (8.0 g) and B (1.5 g). Fraction A acetate contained acetylated triterpene monols of which the isolation and characterization have been reported recently. [1] [2] [3] [4] [5] Upon column chromatography on silica gel [silica gel, 70 g; eluant, nhexane-EtOAc (4 : 1)], the fraction B acetate yielded six fractions with the ascending order of polarity: fractions B1 (292 mg), B2 (201 mg), B3 (112 mg), B4 (126 mg), B5 (107 mg), and B6 (212 mg). Fractions B1-B6 were subjected to preparative HPLC which yielded: dammarenediol II 3-acetate (5a; 67.0 mg, t R 28.9 min) from fraction B1; 3-epicabraleadiol 3-acetate (2a; 11.0 mg, t R 31.4 min), ocotillol I 3-acetate (4a; 2.0 mg, t R 33.4 min), 5a (5.0 mg), and lupane-3b,20-diol (7a; 5.4 mg, t R 37.8 min) from fraction B2; 2a (1.0 mg), ocotillol II 3-acetate (3a; 3.3 mg, t R 29.2 min), and 7a (3.2 mg) from fraction B3; 3-epicabraleadiolhydroxylactone 3-acetate (1a; 3.7 mg, t R 12.5 min), 3a (0.5 mg), and (20R)-taraxastane-3b,20-diol 3-acetate (6a; 4.5 mg, t R 48.4 min) from fraction B4; and 1a (12.2 mg) from fraction B5. Alkaline hydrolysis of the acetates 1a-7a afforded the corresponding free alcohols 1-7.
Preparation of 3-Epicabraleadiolhydroxylactone 3-Acetate (1a) 3-Epicabraleadiol 3-acetate (2a; 10 mg) was added to a stirred solution of CrO 3 (5 mg) in pyridine (2 ml). 11) After stirring for 48 h, water was added and the product was extracted with diethyl ether and washed with water. The solvent was evaporated and the residue was subjected to preparative HPLC to give 1a (2 mg; mp 230-233°C). The MS and 1 H-NMR data of the semisynthetic 1a were essentially the same as those of 1a isolated from the NSL fraction of camellia oil.
Identification and Characterization Identification of 2 and 5 was performed by spectral (MS, 1 H-, C-NMR), 3, 17, 18) 4 (MS and 1 H-NMR), 19) and 7 (MS, 1 H-,
13
C-NMR). 20) The stereochemistry at C-20 of compound 6, identified by MS and 1 H-NMR comparison with those of taraxastane-3b,20-diol 7, 8, 21) and by two-dimensional NMR experiments, was determined based on a NOESY experiment. The spectral data along with some physical characteristics are given below for compounds 1 and 6, along with those for their 3-acetyl derivatives.
3-Epicabraleahydroxylactone (1) 6 cells/ml) were incubated in 1 ml of the medium containing 4 mM n-butyric acid as an inducer, 32 pM of TPA [20 ng/ml in dimethyl sulfoxide (DMSO)], and a known amount (32, 16, 3.2, 0.32 nmol) of the test compound at 37°C in a CO 2 incubator. After 48 h, the cell suspensions were centrifuged at 1000 rpm for 10 min, and the supernatant was re- moved. The activated cells were stained with high-titer EBV-EA-positive sera from nasopharyngeal carcinoma patients, and the conventional indirect immunofluorescence technique was employed for detection. In each assay, at least 500 cells were counted and the experiments were repeated three times. The mean extent of EA induction was determined and compared with that on positive control experiments in which the cells were treated with n-butyric acid plus TPA where the extent of EA induction was ordinarily more than around 40%. The viability of treated Raji cells was assayed by the Trypan blue staining method. 22) 
